Matthias Kretzler

University of Michigan–Ann Arbor

Papers

1

Total Citations

461

H-Index

1

About

Dr. Matthias Kretzler is a leading figure in nephrology whose research has fundamentally reshaped our understanding of kidney disease. His work sits at the intersection of molecular biology, genomics, and regenerative medicine. A major contribution is his pioneering use of high-throughput screening to refine the differentiation of human pluripotent stem cells into kidney organoids, a breakthrough detailed in his highly cited 2018 paper (461 citations). This work not only enhanced organoid maturation but also enabled automated, multidimensional phenotyping, providing a powerful platform for disease modeling and drug discovery. Beyond organoids, Dr. Kretzler is renowned for his leadership in large-scale, systems-level analyses of diabetic kidney disease and glomerular disorders, where he has identified key molecular pathways and biomarkers. His work has garnered thousands of citations, reflecting its profound impact on both basic science and clinical nephrology. Through his role as a principal investigator in major consortia, he continues to drive the field toward precision medicine, offering new hope for patients with chronic kidney disease.

Research Focus

Key Achievements

1
H-Index
1
Papers
461
Total Citations
461
Avg Citations/Paper
🏆 Most Cited Paper
High-Throughput Screening Enhances Kidney Organoid Differentiation from Human Pluripotent Stem Cells and Enables Automated Multidimensional Phenotyping
461 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: University of Michigan–Ann Arbor

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago